Aspiriant LLC’s SLB Ltd SLB Stock Holding History

Aspiriant LLC’s Portfolio SLB Stock Details SLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Sell	4,971 -719	-13%	-$34.9K	0.01%	302
2025 Q4	$218K	Buy	+5,690	New	+$206K	0.01%	310
2018 Q4	–	Sell	-5,977	Closed	-$366K	–	250
2018 Q3	$366K	Sell	5,977 -1,367	-19%	-$88K	0.03%	176
2018 Q2	$492K	Sell	7,344 -1,971	-21%	-$135K	0.04%	160
2018 Q1	$603K	Buy	+9,315	New	+$651K	0.05%	142
2017 Q4	–	Sell	-13,689	Closed	-$955K	–	164
2017 Q3	$955K	Sell	13,689 -4,688	-26%	-$310K	0.08%	109
2017 Q2	$1.21M	Sell	18,377 -2,699	-13%	-$193K	0.11%	102
2017 Q1	$1.65M	Sell	21,076 -2,311	-10%	-$189K	0.14%	92
2016 Q4	$1.96M	Buy	23,387 +195	+0.8%	+$16K	0.18%	75
2016 Q3	$1.82M	Sell	23,192 -930	-4%	-$73.8K	0.18%	74
2016 Q2	$2.08M	Sell	24,122 -493	-2%	-$37.8K	0.2%	72
2016 Q1	$1.81M	Buy	+24,615	New	+$1.73M	0.17%	74
2015 Q3	–	Sell	-2,711	Closed	-$234K	–	119
2015 Q2	$234K	Buy	+2,711	New	+$245K	0.02%	101

Other funds holding SLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aspiriant LLC's SLB Position: Q1 2026 in Review

Aspiriant LLC reduced its SLB Ltd (SLB) stake by 13% in Q1 2026, selling an estimated $34.9K and leaving 4,971 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #302.

Aspiriant LLC first reported a position in SLB in Q2 2015 and has held it in 13 quarters since. The position peaked at $2.08M in Q2 2016. 1,680 funds tracked by Wall St. Rank hold SLB as of Q1 2026.

Aspiriant LLC held 4,971 shares of SLB Ltd worth $255K as of Q1 2026.
Aspiriant LLC sold 719 SLB Ltd shares in Q1 2026, an estimated $34.9K.
SLB Ltd made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #302 holding.
Aspiriant LLC first reported a position in SLB Ltd in Q2 2015 and has held it in 13 quarters since.
Aspiriant LLC's SLB Ltd position peaked at $2.08M in Q2 2016.
1,680 funds tracked by Wall St. Rank held SLB Ltd as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.